Literature DB >> 10334381

Human type I interferons differ greatly in their effects on the proliferation of primary B cells.

L Hibbert1, G R Foster.   

Abstract

We examined the effects of eight subtypes of human interferon-alpha (IFN-alpha) and human IFN-beta on primary human B cells. In costimulation with antibodies to IgM (but not to CD40), some of these induced the cells to proliferate (but not to differentiate). Individual IFN differed greatly in their relative proliferative effects. IFN-alpha8 at 0.1-0.5 ng/ml induced proliferation, whereas most other subtypes were active only at concentrations >5 ng/ml, and IFN-alpha1 was inactive. These marked differences were not due to a selective overall increase in B cell response only to some IFN subtypes, as all those tested similarly induced the IFN-inducible genes 6-16 and HLA class I. Our results show that human B cells must respond to type I IFN via two distinct pathways. One is specific for IFN-alpha8 but can be activated by other IFN at relatively high concentrations. The other responds to them all and causes activation of IFN-inducible genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334381     DOI: 10.1089/107999099314009

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  11 in total

1.  Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells.

Authors:  Richard Szubin; W L William Chang; Tamara Greasby; Laurel Beckett; Nicole Baumgarth
Journal:  J Interferon Cytokine Res       Date:  2008-12       Impact factor: 2.607

2.  Major differences in the responses of primary human leukocyte subsets to IFN-beta.

Authors:  Anette H H van Boxel-Dezaire; Joana A Zula; Yaomin Xu; Richard M Ransohoff; James W Jacobberger; George R Stark
Journal:  J Immunol       Date:  2010-10-18       Impact factor: 5.422

3.  Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases.

Authors:  Amy D Brideau-Andersen; Xiaojian Huang; Siu-Chi Chang Sun; Teddy T Chen; Diane Stark; Ian J Sas; Linda Zadik; Glenn N Dawes; Douglas R Guptill; Robert McCord; Sridhar Govindarajan; Ajoy Roy; Shumin Yang; Judy Gao; Yong Hong Chen; Niels Jørgen Ø Skartved; Annette K Pedersen; David Lin; Christopher P Locher; Indrani Rebbapragada; Anne Dam Jensen; Steven H Bass; Torben L Straight Nissen; Sridhar Viswanathan; Graham R Foster; Julian A Symons; Phillip A Patten
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

Review 4.  The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

Authors:  Consuelo M López de Padilla; Timothy B Niewold
Journal:  Gene       Date:  2015-09-26       Impact factor: 3.688

5.  Identification of differentially expressed genes in blood cells of narcolepsy patients.

Authors:  Susumu Tanaka; Yutaka Honda; Makoto Honda
Journal:  Sleep       Date:  2007-08       Impact factor: 5.849

Review 6.  Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes.

Authors:  Monikaben Padariya; Alicja Sznarkowska; Sachin Kote; Maria Gómez-Herranz; Sara Mikac; Magdalena Pilch; Javier Alfaro; Robin Fahraeus; Ted Hupp; Umesh Kalathiya
Journal:  Biomolecules       Date:  2021-04-22

7.  Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus.

Authors:  Kanae Akita; Ken Yasaka; Tsuyoshi Shirai; Tomonori Ishii; Hideo Harigae; Hiroshi Fujii
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

8.  Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.

Authors:  Wibke Bayer; Ruth Lietz; Teona Ontikatze; Lena Johrden; Matthias Tenbusch; Ghulam Nabi; Simone Schimmer; Peter Groitl; Hans Wolf; Cassandra M Berry; Klaus Uberla; Ulf Dittmer; Oliver Wildner
Journal:  Retrovirology       Date:  2011-09-26       Impact factor: 4.602

9.  Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent.

Authors:  Philippa Hillyer; Viraj P Mane; Lynnsie M Schramm; Montserrat Puig; Daniela Verthelyi; Aaron Chen; Zeng Zhao; Maria B Navarro; Kevin D Kirschman; Srikant Bykadi; Ronald G Jubin; Ronald L Rabin
Journal:  Immunol Cell Biol       Date:  2012-01-17       Impact factor: 5.126

10.  Gene expression profiles in Finnish twins with multiple sclerosis.

Authors:  Silja Särkijärvi; Hanna Kuusisto; Raija Paalavuo; Mari Levula; Nina Airla; Terho Lehtimäki; Jaakko Kaprio; Markku Koskenvuo; Irina Elovaara
Journal:  BMC Med Genet       Date:  2006-02-27       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.